Kaida BioPharma Launches Social Media Channels
September 18, 2024 10:00 ET
|
Kaida Biopharma
Company dedicated to providing a new hope for patients with treatment-resistant gynecological cancers Lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1...
Kaida BioPharma to Present at the Virtual Investor Pitch Conference
June 17, 2024 07:30 ET
|
Kaida Biopharma
Live webcast on Monday, June 17th at 9:00 AM ET FORT LAUDERDALE, FL, June 17, 2024 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to...
Ovarian Cancer Treatment Market To Reach USD 18.3 Billion By 2031. By TMR
November 02, 2023 10:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion...
Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight
September 14, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight Around 100+ key companies are developing therapies for...